A reduced dose of fluconazole as primary antifungal prophylaxis is not associated with increased risk of invasive fungal infections after allogeneic stem cell transplantation from a HLA identical sibling-Reference-Cited by-同舟云学术

A reduced dose of fluconazole as primary antifungal prophylaxis is not associated with increased risk of invasive fungal infections after allogeneic stem cell transplantation from a HLA identical sibling

Published:2018-05-16 Issue:4 Volume:20 Page:e12906
ISSN:1398-2273
Container-title:Transplant Infectious Disease
language:en
Short-container-title:Transpl Infect Dis

Author:

Sarina Barbara¹,Mariotti Jacopo¹^ORCID,Bramanti Stefania¹,Morabito Lucio¹,Crocchiolo Roberto¹,Rimondo Andrea¹,Tordato Federica²,Pocaterra Daria²,Casari Erminia²,De Philippis Chiara¹,Carlo-Stella Carmelo³,Santoro Armando³,Castagna Luca¹

Affiliation:

1. Bone Marrow Unit; Humanitas Cancer Center; Istituto Clinico Humanitas; Rozzano Italy

2. Infectious Diseases Unit; Hospital Health Direction; IRCCS Istituto Clinico Humanitas; Rozzano Italy

3. Hematology Department; Humanitas Cancer Center; Istituto Clinico Humanitas; Rozzano Italy

Publisher

Wiley

Subject

Infectious Diseases,Transplantation

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/tid.12906/fullpdf

Reference29 articles.

1. Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study-Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne;Pagano;Clin Infect Dis,2007